Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Shannon Michelle MacDonald, M.D.

Co-Author

This page shows the publications co-authored by Shannon MacDonald and Nancy Tarbell.
Connection Strength

4.911
  1. Bicentric Treatment Outcomes After Proton Therapy for Nonmyxopapillary High-Grade Spinal Cord Ependymoma in Children. Int J Radiat Oncol Biol Phys. 2021 Sep 29.
    View in: PubMed
    Score: 0.247
  2. Clinical outcomes of pediatric patients with autism spectrum disorder and other neurodevelopmental disorders and intracranial germ cell tumors. Pediatr Blood Cancer. 2021 Aug; 68(8):e28935.
    View in: PubMed
    Score: 0.238
  3. Proton Radiation Therapy for Pediatric Craniopharyngioma. Int J Radiat Oncol Biol Phys. 2021 08 01; 110(5):1480-1487.
    View in: PubMed
    Score: 0.238
  4. Proton Therapy for Pediatric Ependymoma: Mature Results From a Bicentric Study. Int J Radiat Oncol Biol Phys. 2021 07 01; 110(3):815-820.
    View in: PubMed
    Score: 0.236
  5. Evaluating Intensity Modulated Proton Therapy Relative to Passive Scattering Proton Therapy for Increased Vertebral Column Sparing in Craniospinal Irradiation in Growing Pediatric Patients. Int J Radiat Oncol Biol Phys. 2017 05 01; 98(1):37-46.
    View in: PubMed
    Score: 0.179
  6. Case 32-2016. A 20-Year-Old Man with Gynecomastia. N Engl J Med. 2016 10 20; 375(16):1567-1579.
    View in: PubMed
    Score: 0.176
  7. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study. Lancet Oncol. 2016 Mar; 17(3):287-298.
    View in: PubMed
    Score: 0.167
  8. Secondary Malignancy Risk Following Proton Radiation Therapy. Front Oncol. 2015; 5:261.
    View in: PubMed
    Score: 0.165
  9. Incidence of CNS Injury for a Cohort of 111 Patients Treated With Proton Therapy for Medulloblastoma: LET and RBE Associations for Areas of Injury. Int J Radiat Oncol Biol Phys. 2016 May 01; 95(1):287-296.
    View in: PubMed
    Score: 0.163
  10. Cost effectiveness of proton versus photon radiation therapy with respect to the risk of growth hormone deficiency in children. Cancer. 2015 May 15; 121(10):1694-702.
    View in: PubMed
    Score: 0.156
  11. Patterns of failure after proton therapy in medulloblastoma; linear energy transfer distributions and relative biological effectiveness associations for relapses. Int J Radiat Oncol Biol Phys. 2014 Mar 01; 88(3):655-63.
    View in: PubMed
    Score: 0.146
  12. Proton radiotherapy for pediatric central nervous system ependymoma: clinical outcomes for 70 patients. Neuro Oncol. 2013 Nov; 15(11):1552-9.
    View in: PubMed
    Score: 0.142
  13. Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy. Cancer. 2014 Jan 01; 120(1):126-33.
    View in: PubMed
    Score: 0.142
  14. Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma. Cancer. 2013 Dec 15; 119(24):4299-307.
    View in: PubMed
    Score: 0.142
  15. Delayed diagnosis in children with intracranial germ cell tumors. J Pediatr. 2013 Nov; 163(5):1448-53.
    View in: PubMed
    Score: 0.140
  16. Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy. Int J Radiat Oncol Biol Phys. 2013 Sep 01; 87(1):120-6.
    View in: PubMed
    Score: 0.139
  17. Bifocal intracranial tumors of nongerminomatous germ cell etiology: diagnostic and therapeutic implications. Neuro Oncol. 2013 Jul; 15(7):955-60.
    View in: PubMed
    Score: 0.138
  18. Early clinical outcomes using proton radiation for children with central nervous system atypical teratoid rhabdoid tumors. Int J Radiat Oncol Biol Phys. 2013 May 01; 86(1):114-20.
    View in: PubMed
    Score: 0.137
  19. A phase II trial of proton radiotherapy for medulloblastoma: Preliminary results. J Clin Oncol. 2010 Jun 20; 28(18_suppl):CRA9507.
    View in: PubMed
    Score: 0.113
  20. Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes. Int J Radiat Oncol Biol Phys. 2011 Jan 01; 79(1):121-9.
    View in: PubMed
    Score: 0.112
  21. Proton radiotherapy for childhood ependymoma: initial clinical outcomes and dose comparisons. Int J Radiat Oncol Biol Phys. 2008 Jul 15; 71(4):979-86.
    View in: PubMed
    Score: 0.097
  22. Intellectual functioning among case-matched cohorts of children treated with proton or photon radiation for standard-risk medulloblastoma. Cancer. 2021 Oct 15; 127(20):3840-3846.
    View in: PubMed
    Score: 0.061
  23. Circulating Lymphocyte Counts Early During Radiation Therapy Are Associated With Recurrence in Pediatric Medulloblastoma. Int J Radiat Oncol Biol Phys. 2021 07 15; 110(4):1044-1052.
    View in: PubMed
    Score: 0.059
  24. Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapy. Neuro Oncol. 2021 01 30; 23(1):156-166.
    View in: PubMed
    Score: 0.059
  25. Long-term health-related quality of life in pediatric brain tumor survivors receiving proton radiotherapy at <4 years of age. Neuro Oncol. 2020 09 29; 22(9):1379-1387.
    View in: PubMed
    Score: 0.058
  26. Revisiting the Role of Radiation Therapy for Pediatric Low-Grade Glioma. J Clin Oncol. 2019 12 10; 37(35):3335-3339.
    View in: PubMed
    Score: 0.054
  27. Moody D. Wharam Jr, MD, FACR, FASTRO, July 22, 1941-August 10, 2018. Int J Radiat Oncol Biol Phys. 2019 Apr 01; 103(5):1026-1030.
    View in: PubMed
    Score: 0.052
  28. Increased distance from a treating proton center is associated with diminished ability to follow patients enrolled on a multicenter radiation oncology registry. Radiother Oncol. 2019 05; 134:25-29.
    View in: PubMed
    Score: 0.051
  29. Larry Emanuel Kun, March 10, 1946-May 27, 2018. Int J Radiat Oncol Biol Phys. 2019 Jan 01; 103(1):8-14.
    View in: PubMed
    Score: 0.051
  30. Endocrine Deficiency As a Function of Radiation Dose to the Hypothalamus and Pituitary in Pediatric and Young Adult Patients With Brain Tumors. J Clin Oncol. 2018 10 01; 36(28):2854-2862.
    View in: PubMed
    Score: 0.050
  31. Quality of life in patients with proton-treated pediatric medulloblastoma: Results of a prospective assessment with 5-year follow-up. Cancer. 2018 08; 124(16):3390-3400.
    View in: PubMed
    Score: 0.049
  32. Cognitive and Adaptive Outcomes After Proton Radiation for Pediatric Patients With Brain Tumors. Int J Radiat Oncol Biol Phys. 2018 10 01; 102(2):391-398.
    View in: PubMed
    Score: 0.049
  33. Estimated IQ Systematically Underestimates Neurocognitive Sequelae in Irradiated Pediatric Brain Tumor Survivors. Int J Radiat Oncol Biol Phys. 2018 07 01; 101(3):541-549.
    View in: PubMed
    Score: 0.048
  34. Left hippocampal dosimetry correlates with visual and verbal memory outcomes in survivors of pediatric brain tumors. Cancer. 2018 05 15; 124(10):2238-2245.
    View in: PubMed
    Score: 0.048
  35. Executive functioning, academic skills, and quality of life in pediatric patients with brain tumors post-proton radiation therapy. J Neurooncol. 2018 Mar; 137(1):119-126.
    View in: PubMed
    Score: 0.047
  36. Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric Factors. Int J Radiat Oncol Biol Phys. 2018 03 01; 100(3):719-729.
    View in: PubMed
    Score: 0.047
  37. Analysis of patient outcomes following proton radiation therapy for retinoblastoma. Adv Radiat Oncol. 2017 Jan-Mar; 2(1):44-52.
    View in: PubMed
    Score: 0.045
  38. Proton beam therapy for medulloblastoma - Author's reply. Lancet Oncol. 2016 05; 17(5):e174-5.
    View in: PubMed
    Score: 0.042
  39. Endocrine outcomes with proton and photon radiotherapy for standard risk medulloblastoma. Neuro Oncol. 2016 06; 18(6):881-7.
    View in: PubMed
    Score: 0.041
  40. Clinical Outcomes Among Children With Standard-Risk Medulloblastoma Treated With Proton and Photon Radiation Therapy: A Comparison of Disease Control and Overall Survival. Int J Radiat Oncol Biol Phys. 2016 Jan 01; 94(1):133-138.
    View in: PubMed
    Score: 0.041
  41. Use of proton therapy for re-irradiation in pediatric intracranial ependymoma. Radiother Oncol. 2015 Aug; 116(2):301-8.
    View in: PubMed
    Score: 0.040
  42. Early Cognitive Outcomes Following Proton Radiation in Pediatric Patients With Brain and Central Nervous System Tumors. Int J Radiat Oncol Biol Phys. 2015 Oct 01; 93(2):400-7.
    View in: PubMed
    Score: 0.040
  43. Local failure in parameningeal rhabdomyosarcoma correlates with poor response to induction chemotherapy. Int J Radiat Oncol Biol Phys. 2015 Jun 01; 92(2):358-67.
    View in: PubMed
    Score: 0.039
  44. Proton therapy for pediatric and adolescent esthesioneuroblastoma. Pediatr Blood Cancer. 2015 Sep; 62(9):1523-8.
    View in: PubMed
    Score: 0.039
  45. Evaluation of permanent alopecia in pediatric medulloblastoma patients treated with proton radiation. Radiat Oncol. 2014 Nov 18; 9:220.
    View in: PubMed
    Score: 0.038
  46. Preliminary results of a phase II trial of proton radiotherapy for pediatric rhabdomyosarcoma. J Clin Oncol. 2014 Nov 20; 32(33):3762-70.
    View in: PubMed
    Score: 0.038
  47. A dosimetric comparison of proton and intensity modulated radiation therapy in pediatric rhabdomyosarcoma patients enrolled on a prospective phase II proton study. Radiother Oncol. 2014 Oct; 113(1):77-83.
    View in: PubMed
    Score: 0.038
  48. Quality of life outcomes in proton and photon treated pediatric brain tumor survivors. Radiother Oncol. 2014 Oct; 113(1):89-94.
    View in: PubMed
    Score: 0.038
  49. Proton radiation therapy for the treatment of retinoblastoma. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):863-9.
    View in: PubMed
    Score: 0.038
  50. Clinical outcomes and late endocrine, neurocognitive, and visual profiles of proton radiation for pediatric low-grade gliomas. Int J Radiat Oncol Biol Phys. 2014 Aug 01; 89(5):1060-1068.
    View in: PubMed
    Score: 0.037
  51. Natural history and role of radiation in patients with supratentorial and infratentorial WHO grade II ependymomas: results from a population-based study. J Neurooncol. 2013 Dec; 115(3):411-9.
    View in: PubMed
    Score: 0.035
  52. Prospective study of health-related quality of life for children with brain tumors treated with proton radiotherapy. J Clin Oncol. 2012 Jun 10; 30(17):2079-86.
    View in: PubMed
    Score: 0.032
  53. Proton radiotherapy for pediatric Ewing's sarcoma: initial clinical outcomes. Int J Radiat Oncol Biol Phys. 2012 Mar 01; 82(3):1142-8.
    View in: PubMed
    Score: 0.031
  54. Proton radiotherapy for parameningeal rhabdomyosarcoma: clinical outcomes and late effects. Int J Radiat Oncol Biol Phys. 2012 Feb 01; 82(2):635-42.
    View in: PubMed
    Score: 0.030
  55. Proton radiotherapy for pediatric bladder/prostate rhabdomyosarcoma: clinical outcomes and dosimetry compared to intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2011 Dec 01; 81(5):1367-73.
    View in: PubMed
    Score: 0.029
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.